1. Genetic and Epigenetic Modifications in Pancreatic Cancer
    Sanjay Kumar et al, 2018, Epigenetic Mechanisms in Cancer CrossRef
  2. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy
    Dan Chen et al, 2017, Tumor Biology CrossRef
  3. Involvement and Clinical Aspects of MicroRNA in Osteosarcoma
    Ram Ram Kumar et al, 2016, International Journal of Molecular Sciences CrossRef
  4. miR-375 controls porcine pancreatic stem cell fate by targeting 3-phosphoinositide-dependent protein kinase-1(Pdk1)
    Shuxian Hu et al, 2016, Cell Proliferation CrossRef
  5. Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab
    Adrien Costantini et al, 2018, OncoImmunology CrossRef
  6. The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
    Gabriella Simões Heyn et al, 2020, Frontiers in Endocrinology CrossRef
  7. Oridonin alters the expression profiles of MicroRNAs in BxPC-3 human pancreatic cancer cells
    Zhifang Gui et al, 2015, BMC Complementary and Alternative Medicine CrossRef
  8. Circulating RNAs as new biomarkers for detecting pancreatic cancer
    Takahiro Kishikawa, 2015, World Journal of Gastroenterology CrossRef
  9. MiR-375: A novel multifunctional regulator
    Yang Liu et al, 2021, Life Sciences CrossRef
  10. Sulfiredoxin-1 exerts anti-apoptotic and neuroprotective effects against oxidative stress-induced injury in rat cortical astrocytes following exposure to oxygen-glucose deprivation and hydrogen peroxide
    YUNCHUAN ZHOU et al, 2015, International Journal of Molecular Medicine CrossRef
  11. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
    Janusz Matuszyk, 2022, Molecular Medicine CrossRef
  12. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2
    SILIANG WANG et al, 2014, Oncology Reports CrossRef
  13. The effect of LOXL2 in hepatocellular carcinoma
    Linghong Wu et al, 2016, Molecular Medicine Reports CrossRef